OncWeekly Content Page - Page 5

CLL (Chronic Lymphocytic Leukemia),Leukemia

Genomic Abnormalities And Mutations Evaluated As Prognostic Factors For Therapy In Patients With CLL

Apr 20, 2023

CLL (Chronic Lymphocytic Leukemia),Leukemia

Ibrutinib Improves OS in CLL Patients ≥65 Years as First-Line Treatment

Mar 10, 2023

CLL (Chronic Lymphocytic Leukemia),Leukemia

4-Year Follow-Up Data of Ibrutinib and Venetoclax Combo in CLL Patients

Mar 10, 2023

CLL (Chronic Lymphocytic Leukemia),Leukemia

Comparing Venetoclax and Chemoimmunotherapy for CLL: GAIA/CLL13 Phase 3 Trial

Mar 10, 2023

Advertisement

CLL (Chronic Lymphocytic Leukemia),Leukemia

CLL13/GAIA Trial: FCR/BR vs. RVE, GVE, and GIVE Treatment Outcomes

Mar 10, 2023

CLL (Chronic Lymphocytic Leukemia),Leukemia

Phase I/II Study on Mosunetuzumab's PD Biomarkers in NHL Patients

Mar 10, 2023

CLL (Chronic Lymphocytic Leukemia),Leukemia

Safety of Subcutaneous Mosunetuzumab in Refractory B-Cell Lymphomas: Trial Results

Mar 07, 2023

CLL (Chronic Lymphocytic Leukemia),Leukemia

Mosunetuzumab Shows Promise in R/R Follicular Lymphoma Treatment: Phase II Results

Mar 07, 2023

Previous
1
…
3
4
5
6
Next

Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Newsletter

Advertisement